DR. SHANTA CHAWLA, MD
Osteopathic Medicine at Modesto, Irvine, CA
License number
California C50899
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
34 Modesto, Irvine, CA 92602
Phone
(714) 389-1555
Personal information
See more information about SHANTA CHAWLA at radaris.comName
Address
Phone
3521 Braxton Cmn, Fremont, CA 94538
34 Modesto, Irvine, CA 92602
450 S Mathilda Ave, Sunnyvale, CA 94086
41686 Meiggs St, Fremont, CA 94538
3521 Braxton Cmn, Fremont, CA 94538
Professional information
See more information about SHANTA CHAWLA at trustoria.com
Dr. Shanta Chawla, Irvine CA - MD (Doctor of Medicine)
Dr. Shanta Chawla, Irvine CA - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
34 Modesto, Irvine 92602
(714) 389-1555 (Phone)
(714) 389-1555 (Phone)
Certifications:
Internal Medicine, 1979
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Delhi / Maulana Azad Medical College
University of Delhi / Maulana Azad Medical College
Intravesical Apaziquone Administration Following Transurethral Resection
Intravesical Apaziquone Administration Following Transurethral Resection
US Patent:
2008022, Sep 18, 2008
Filed:
Mar 13, 2008
Appl. No.:
12/048178
Inventors:
Luigi Lenaz - Newton PA, US
Shanta Chawla - Irvine CA, US
Mario Beer - San Clemente CA, US
Shanta Chawla - Irvine CA, US
Mario Beer - San Clemente CA, US
International Classification:
A61K 31/403, A61P 35/00
US Classification:
514414
Abstract:
Bladder cancer treatments include the intravesical administration of apaziquone immediately (e.g. within about 6 hours) following transurethral resection.
Bladder Cancer Treatment And Methods
Bladder Cancer Treatment And Methods
US Patent:
2011028, Nov 24, 2011
Filed:
Apr 8, 2011
Appl. No.:
13/083428
Inventors:
Bastiaan Nuijen - Amsterdam, NL
Ernie Pfadenhauer - Irvine CA, US
Jos H. Beijnen - Amsterdam, NL
Luigi Lenaz - Newton PA, US
Shanta Chawla - Irvine CA, US
Mario Beer - San Clemente CA, US
Ernie Pfadenhauer - Irvine CA, US
Jos H. Beijnen - Amsterdam, NL
Luigi Lenaz - Newton PA, US
Shanta Chawla - Irvine CA, US
Mario Beer - San Clemente CA, US
International Classification:
A61M 37/00, A61P 35/00, A61K 31/404
US Classification:
604 22, 514414
Abstract:
Therapeutic compositions comprising an indoloquinone compound and various bladder cancer treatments and methods are disclosed. More specifically, bladder cancer treatments include the intravesical administration of apaziquone immediately following transurethral resection. Also disclosed are therapeutic compositions comprising an indoloquinone compound and a formulation vehicle. The formulation vehicle improves the solubility and stability of the indoloquinone compound. Additionally, the coating compositions can include coating agents that provide better adhesion of the coating composition to the bladder wall during intravesical delivery of the coating composition.
Indoloquinone Tumor Radiation Sensitization
Indoloquinone Tumor Radiation Sensitization
US Patent:
2006022, Oct 5, 2006
Filed:
Mar 31, 2006
Appl. No.:
11/278299
Inventors:
Randy Burd - Oro Valley AZ, US
Luigi Lenaz - Newton PA, US
Shanta Chawla - Irvine CA, US
Guru Reddy - Irvine CA, US
Adam Dicker - Cherry Hill NJ, US
Luigi Lenaz - Newton PA, US
Shanta Chawla - Irvine CA, US
Guru Reddy - Irvine CA, US
Adam Dicker - Cherry Hill NJ, US
International Classification:
A61K 31/404
US Classification:
514418000
Abstract:
This invention generally relates to Indoloquinone caused tumor radiation therapy sensitization. More specifically, this invention relates to the discovery of indoloquinones as a radiation sensitizer (radiation therapy adjuvant) due to its ability to selectively target hypoxic cells and to damage the DNA of these hypoxic cells. Indoloquinones do so with minimal normal cell and tissue toxicity.